Clinical Trials · NCT01618162
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 435
- Start date
- Aug 2012
- Locations
- 87 sites, 8 countries
- Primary endpoint
- Change in Glycosylated Haemoglobin (HbA1c)